Preparation, Characterization and Preliminary in vivo Testing of Liposomated Antiidiotypic Antibodies Against Morphine Derivatives
https://doi.org/10.33647/2074-5982-17-4-8-17
Abstract
Artificial membrane structures containing medicinal substances are highly promising for the development of new drugs. Liposomal preparations are actively used in medical practice due to their high efficacy and relatively low toxicity. Our aim was to encapsulate anti-idiotypic antibodies into a liposomal composition with the purpose of improving their immunogenic properties. Following the preparation of a liposomal composition by the dehydration/rehydration method using ultrasonic treatment, the size, zeta potential, and loading efficiency of liposomes were investigated. Preliminary in vivo studies were conducted to evaluate the adjuvant properties of liposomes of varying size. Loaded liposomes of the smallest diameter (about 110 nm) showed the potential of enhancing the immune response similar to that obtained using Freund’s adjuvant. These results justify further research into the properties of liposomes loaded with antibodies.
About the Authors
V. N. KarkischenkoRussian Federation
Vladislav N. Karkischenko, Dr. Sci. (Med.), Prof.
143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1
A. G. Berzina
Russian Federation
Asya G. Berzina, Cand. Sci. (Biol.)
119034, Moscow, Kropotkinskiy Lane, 23
T. A. Klimova
Russian Federation
Tatiana A. Klimova, Cand. Sci. (Biol.)
119034, Moscow, Kropotkinskiy Lane, 23
N. B. Gamaleya
Russian Federation
Natalia B. Gamaleya, Dr. Sci. (Med.), Prof.
119034, Moscow, Kropotkinskiy Lane, 23
R. A. Ageldinov
Russian Federation
Ruslan A. Ageldinov
143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1
125047, Moscow, Miusskaya Square, 9
A. E. Kuznetsov
Russian Federation
Alexander E. Kuznetsov, Cand. Sci. (Tech.)
125047, Moscow, Miusskaya Square, 9
I. S. Korsun
Russian Federation
Irina S. Korsun
125047, Moscow, Miusskaya Square, 9
M. S. Nesterov
Russian Federation
Maksim S. Nesterov
143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1
L. I. Ulyanova
Russian Federation
Lyudmila I. Ulyanova, Dr. Sci. (Biol.)
119034, Moscow, Kropotkinskiy Lane, 23
References
1. Averina E.S., Bodoev N.V., Zhamsaranova S.D., Lamadzhanova G.P., Radanayeva L.D. Immunomodeliruyushchaya aktivnost’ liposomal’nyh sredstv, poluchennyh iz koncentratov zhira bajkal’skoj nerpy [Immunomulating activity of liposomal funds derived from fat concentrates of the Baikal Nerze]. Vestnik novyh medicinskih tekhnologij [Bulletin of new medical technology]. 2003;X(3):84–86. (In Russian).
2. Gamaleya N.B., Berzina A.G., Shestakov K.A., Kapanadze G.D., Revyakin A.O., Fokin Yu.V. Immunogen dlya lecheniya i profilaktiki zavisimosti ot opiatov [Immunogen for the treatment and prevention of opiate dependence]. Patent RF No. 2548802, 2015. (In Russian).
3. Goryaev A.A., Savkina M.V., Obukhov Yu.I., Merkulov V.A., Olefir Yu.V. DNK- i RNK- vakciny: sovremennoe sostoyanie, trebovaniya k kachestvu i osobennosti provedeniya doklinicheskih issledovanij [DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies]. BIOpreparaty. Profilaktika, diagnostika, lechenie [BIO-preparations. Prevention, Diagnosis, Treatement]. 2019;19(2):72–80. (In Russian).
4. Kathy D., Raikundalia Ch., Brown J., Ling N.R. Antitela, metody [Antibodies. A practical approach]. Vol. 1. Transl. from English. Moscow: Mir Publ., 1991:287. (In Russian).
5. Trofimov A.V., Atanesyan V.A., Ischenko A.M., Karabanova E.A., Rak A.Ya., Simbirtsev A.S., Gamaleya N.B., Berzina A.G., Stankova N.V., Kapanadze G.D., Ulyanova L.I., Klimova T.A. Poluchenie poliklonal’nykh i monoklonal’nykh antiidiotipicheskikh antitel k morfin-spetsificheskim immunoglobulinam [Preparation of polyclonal and monoclonal anti-idiotypic antibodies against morphine-specific immunoglobulins]. Meditsinskaya immunologiya [Medical Immunology]. 2020;22(1):187–196. (In Russian).
6. Briuglia M.-L., Rotella C., McFarlane A., Lamprou D.A. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Delivery and Translational Research. 2015;5(3):231–242.
7. Janine K.T., Tyler J.A., Saikat M., Brittany A.M., Rachel C.S., Esser-Kahn A.P. Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development. Trends in Biotechnology. 2018;10(004):1–16.
8. Laouini A., Jaafar-Maalej C., Limayem-Blouza I., Sfar S., Charcosset C., Fessi H. Preparation, characterization and applications of liposomes: State of the art. J. of Colloid Science and Biotechnology. 2012;1(2):147–168.
9. Olusanya T.O.B, Haj A.R.R., Ibegbu D.M., Smith J.R., Elkordy A.A. liposomal drug delivery systems and anticancer drugs. Molecules. 2018;23(4):907. DOI: 10.3390/molecules23040907.
10. Pathak S.K., Mishra R., Kumar S., Prakash G., Parthasarthy R. Effect of cholesterol concentration on size of liposome. J. of Pharmacy and Biological Sciences. 2012;1(1):50–53.
11. Zahednezhad F., Saadat M., Valizadeh H., Zakeri-Milani P., Baradaran B. Liposome and immune system interplay: Challenges and potentials. J. of Controlled Release. 2019;305:194–209.
Review
For citations:
Karkischenko V.N., Berzina A.G., Klimova T.A., Gamaleya N.B., Ageldinov R.A., Kuznetsov A.E., Korsun I.S., Nesterov M.S., Ulyanova L.I. Preparation, Characterization and Preliminary in vivo Testing of Liposomated Antiidiotypic Antibodies Against Morphine Derivatives. Journal Biomed. 2021;17(4):8-17. (In Russ.) https://doi.org/10.33647/2074-5982-17-4-8-17